Phase II Trial in Subjects with Allergic Asthma Completes Enrolment
29.09.2011 - Phase II Trial in Subjects with Allergic Asthma Completes Enrolment
Pharmaxis today announced it has completed enrolment of all subjects into its Phase II clinical trial evaluating ASM8, a potential new treatment for patients with moderate to severe asthma.